INTRODUCTION: The present study examines cardiovascular risk factor profiles and 24-
month mortality in patients with symptomatic peripheral arterial disease. DESIGN STUDY …

The original TransAtlantic InterSociety Consensus (TASC) on the Management of Peripheral
Arterial Disease (PAD) published in 2000 was the first international consensus on the …

Background: Peripheral artery disease is common and associated with high mortality. There
are limited data detailing causes of death among patients with peripheral artery disease …

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

BACKGROUND: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)
are associated with improved outcome in patients with peripheral arterial disease. Statins …

Background: Previous observational studies reported a wide variation and possible room for
improvement in the treatment of patients suffering from symptomatic peripheral artery …

OBJECTIVES: The Heart Protection Study (HPS) provides an opportunity to assess directly
the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial …

This paper reviews the current epidemiological data on peripheral artery disease (PAD) in
Europe. Cardiovascular disease (CVD) burden is presented and PAD prevalence is …

Objective The aim was to determine long-term mortality rates and the underlying cause of
death for subjects with different peripheral arterial disease (PAD) stages in a population …

Aims The aim was to assess trends in peripheral arterial disease (PAD) incidence and
mortality rates in European Union (15+) countries between 1990 and 2017. Methods and …